Hospital
Crete Area Medical Center
Crete Area Medical Center was paid $2.23M by Medicaid between Jan 2018 and Nov 2024, across 69 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoCRETE AREA MEDICAL CENTER
CRETE, NE 68333
CRETE, NE 68333
33aNPI1063463958assigned 05/15/2006
33bProvider typeCritical Access Hospital
28Total paid$2.23M
24GClaims43,260
24DCodes billed69
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#6 of 53
Median peer was paid$593K
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,276 | $333K | |
| 2019 | 7,060 | $375K | |
| 2020 | 5,446 | $250K | |
| 2021 | 11,655 | $542K | |
| 2022 | 9,247 | $514K | |
| 2023 | 2,609 | $144K | |
| 2024incomplete | 967 | $72K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 2,621 | 2,332 | $552K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 1,594 | 1,267 | $349K |
| 80053 | Comprehensive metabolic panel | 5.7% | 2,889 | 2,528 | $128K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 3,732 | 3,093 | $109K |
| 71046 | Radiologic examination, chest; 2 views | 4.7% | 887 | 785 | $104K |
| 87430 | 4.1% | 2,429 | 2,291 | $92K | |
| 36415 | Collection of venous blood by venipuncture | 3.6% | 7,450 | 6,177 | $81K |
| 87400 | 3.3% | 547 | 504 | $74K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.6% | 2,898 | 1,979 | $57K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 1,273 | 1,129 | $57K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 286 | 260 | $42K |
| 81001 | 1.9% | 2,038 | 1,775 | $42K |
57 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 1,099 | $34K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 1,076 | $34K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 317 | $32K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 410 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 799 | $29K |
| 86140 | 1.2% | 878 | $27K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 427 | $27K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 185 | $25K |
| 0240U | <1% | 154 | $22K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 394 | $21K |
| 80061 | Lipid panel | <1% | 659 | $21K |
| 80050 | General health panel | <1% | 149 | $21K |
| J3490 | Unclassified drugs | <1% | 2,175 | $20K |
| 99285 | Emergency room visit (most serious) | <1% | 58 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 322 | $18K |
| 87631 | <1% | 81 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 660 | $13K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 802 | $11K |
| 87660 | <1% | 216 | $9K | |
| 87510 | <1% | 215 | $9K | |
| 87480 | <1% | 215 | $9K | |
| 84484 | <1% | 203 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 172 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 90 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 129 | $7K |
| 81003 | <1% | 436 | $6K | |
| 84703 | <1% | 101 | $5K | |
| 87634 | <1% | 53 | $5K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $4K |
| 87077 | <1% | 133 | $4K | |
| 87186 | <1% | 97 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 38 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 115 | $3K |
| 81002 | <1% | 187 | $3K | |
| 36416 | <1% | 313 | $2K | |
| 83735 | <1% | 134 | $2K | |
| 83655 | <1% | 53 | $2K | |
| 87420 | <1% | 42 | $2K | |
| 85610 | <1% | 103 | $2K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 523 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $2K |
| 85018 | <1% | 89 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $1K |
| 83690 | <1% | 44 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 25 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 18 | $1K |
| 84145 | <1% | 23 | $1K | |
| 83605 | <1% | 39 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 18 | $1K |
| 97161 | <1% | 12 | $701.44 | |
| 83880 | <1% | 16 | $670.65 | |
| 71045 | Radiologic examination, chest; single view | <1% | 12 | $605.03 |
| 84439 | <1% | 12 | $453.60 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $301.32 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $298.43 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 17 | $128.59 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $66.17 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLACY, JULIE (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Crete Area Medical Center | Crete, NE | $1.87M |
| Crete Area Medical Center | Crete, NE | $241K |
| Crete Area Medical Center | Wilber, NE | $229K |
| Crete Area Medical Center | Friend, NE | $62K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.